BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/8/2016 9:44:00 AM | Browse: 1085 | Download: 2099
 |
Received |
|
2016-02-09 14:19 |
|
Peer-Review Started |
|
2016-02-09 14:50 |
|
To Make the First Decision |
|
2016-03-30 11:47 |
|
Return for Revision |
|
2016-03-31 09:40 |
|
Revised |
|
2016-04-08 23:45 |
|
Second Decision |
|
2016-04-19 18:03 |
 |
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Company Editor-in-Chief |
|
2016-05-09 16:43 |
|
Articles in Press |
|
2016-05-09 16:43 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2016-06-29 16:58 |
|
Publish the Manuscript Online |
|
2016-07-08 09:44 |
| ISSN |
1948-5204 (online) |
| Open Access |
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2016. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Allergy |
| Manuscript Type |
Retrospective Study |
| Article Title |
Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Jae Min Lee, Hong Sik Lee, Jong Jin Hyun, Hyuk Soon Choi, Eun Sun Kim, Bora Keum, Yeon Seok Seo, Yoon Tae Jeen, Hoon Jai Chun, Soon Ho Um and Chang Duck Kim |
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Korea Health Technology R and D Project through the Korea Health Industry Development Institute |
|
| Ministry of Health and Welfare, Republic of Korea |
HI14C3477 |
|
| Corresponding Author |
Hong Sik Lee, MD, PhD, Division of Gastroenterology and Hepatology, Department of Internal Medicine, Korea University College of Medicine, Inchon-ro 73, Seongbuk-gu, Seoul 02841, South Korea. hslee60@korea.ac.kr |
| Key Words |
Pancreatic cancer; Neutrophil-to-lymphocyte ratio; C-reactive protein; Albumin; Prognostic factor |
| Core Tip |
This retrospective study validates the value of systemic inflammation-based markers as prognostic factors for pancreatic cancer (PC). The neutrophil-to-lymphocyte ratio and the C-reactive protein-to-albumin ratio, which can be determined from routine blood tests before chemotherapy, can be used as useful biomarkers in PC to predict a patient’s response to chemotherapy. |
| Publish Date |
2016-07-08 09:44 |
| Citation |
Lee JM, Lee HS, Hyun JJ, Choi HS, Kim ES, Keum B, Seo YS, Jeen YT, Chun HJ, Um SH, Kim CD. Prognostic value of inflammation-based markers in patients with pancreatic cancer administered gemcitabine and erlotinib. World J Gastrointest Oncol 2016; 8(7): 555-562 |
| URL |
http://www.wjgnet.com/1948-5204/full/v8/i7/555.htm |
| DOI |
http://dx.doi.org/10.4251/wjgo.v8.i7.555 |
© 2004-2024 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
